Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 2
2001 8
2002 5
2003 20
2004 19
2005 20
2006 18
2007 21
2008 12
2009 8
2010 7
2011 10
2012 22
2013 21
2014 31
2015 27
2016 32
2017 33
2018 32
2019 43
2020 41
2021 47
2022 28
2023 33
2024 46
2025 39

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

520 results

Results by year

Filters applied: . Clear all
Page 1
Endogenous miRNA Sponges.
Alkan AH, Akgül B. Alkan AH, et al. Methods Mol Biol. 2022;2257:91-104. doi: 10.1007/978-1-0716-1170-8_5. Methods Mol Biol. 2022. PMID: 34432275
Water-Soluble Metallocene-Containing Polymers.
Alkan A, Wurm FR. Alkan A, et al. Macromol Rapid Commun. 2016 Sep;37(18):1482-93. doi: 10.1002/marc.201600205. Epub 2016 Aug 5. Macromol Rapid Commun. 2016. PMID: 27492968 Review.
Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG study.
Beypınar İ, Demir H, Yaslıkaya Ş, Köşeci T, Demir B, Çolak G, Ağaoğlu AB, Şahbazlar M, Şancı PC, Çabuk D, Işık U, Şahin E, Coşkun A, Caner B, Aykut T, Artaç M, Duygulu ME, Sever N, Öksüz S, Turan N, Aykan MB, Tüzün EK, Uysal M, Uğurlu İ, Sakin A, Acar C, Özaşkın D, Şakalar T, Keskinkılıç M, Yavuzşen T, Köse N, Ertürk İ, Yıldırım N, Balçık OY, Alkan A, Selvi O, Erçin E, Ünal OÜ, Karaçin C. Beypınar İ, et al. Among authors: alkan a. Breast Cancer Res Treat. 2024 Dec;208(3):597-604. doi: 10.1007/s10549-024-07456-x. Epub 2024 Aug 9. Breast Cancer Res Treat. 2024. PMID: 39123071
Neoadjuvant Pembrolizumab Plus Chemotherapy in Early-Stage Triple-Negative Breast Cancer: A Nationwide Retrospective Turkish Oncology Group Study.
Karci E, Bilici A, Bayram B, Celayir M, Ozyurt N, Uluc BO, Eken A, Basaran G, Demirci U, Kemal Y, Oruncu MB, Olmez OF, Selcukbiricik F, Korkmaz T, Erturk I, Bilgetekin I, Celik S, Turkel A, Alkan A, Sakin A, Can O, Gunaldi M, Esin E, Yildiz O. Karci E, et al. Among authors: alkan a. Cancers (Basel). 2024 Oct 3;16(19):3389. doi: 10.3390/cancers16193389. Cancers (Basel). 2024. PMID: 39410009 Free PMC article.
Lumbar gossypiboma.
Erdem G, Ateş O, Koçak A, Alkan A. Erdem G, et al. Among authors: alkan a. Diagn Interv Radiol. 2010 Mar;16(1):10-2. doi: 10.4261/1305-3825.DIR.1183-07.1. Epub 2009 Oct 5. Diagn Interv Radiol. 2010. PMID: 19813177 Free article.
The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study.
Özyurt N, Alkan A, Gülbağcı B, Seyyar M, Aşık E, Şahbazlar M, Türker M, Kınıkoğlu O, Yerlikaya T, Dinç G, Aytaç A, Kalkan Z, Ebinç S, Gültürk İ, Keskinkılıç M, İşleyen ZS, Çağlayan D, Türkel A, Aydın E, Şakalar T, Sekmek S, Yıldırım N, Koçak S, Okutur K, Özveren A, Dursun B, Kitaplı S, Eren OÖ, Beypınar İ, Hacıbekiroğlu İ, Çabuk D, Karaman E, Acar Ö, Paydaş S, Eryılmaz MK, Demir B, Oruç Z, Yılmaz M, Biricik FS, Salim DK, Tanrıverdi Ö, Doğan M. Özyurt N, et al. Among authors: alkan a. Sci Rep. 2024 Oct 9;14(1):23556. doi: 10.1038/s41598-024-75293-5. Sci Rep. 2024. PMID: 39384975 Free PMC article.
520 results